See our roundup of today's AIM risers - see the full LSE winners & losers board here.
TomCo Energy rises 11% to 5p a share
TomCo Energy (TOM) shares experienced a large drop on Friday following the news it has had to delay the Field Test on the Company's Holliday Block in Utah.
A greater than anticipated water influx, an unexpected failure in one of the couplings and colder temperature forecasts have delayed the ‘live’ testing stage to Q2 2019.
Shares fell from 8p a share to 4p, but have rebounded slightly this morning
Read more here & follow TOM here:
Frenkel Topping Group rises 7% to 27.5p a share
Frenkel Topping Group (FEN) rises slightly following the announcement that trading is in line with management expectations for the full year to 31 December 2018.
The company made a significant investment to deepen its talent pool and nurture home grown skills, and the group’s Expert Witness revenue has exceeded its annual target, an encouraging indication of future AUM growth
Read more here & follow FEN here:
ImmuPharma (IMM) rises 11% to 10.82p a share
ImmuPharma (IMM) is a specialist drug discovery and development company headquartered in London with research operations in France and Switzerland.
The company is focused on achieving the full regulatory approval of LupuzorTM which it believes has the potential to be a groundbreaking drug for lupus patients with “blockbuster potential in commercial terms”
Read more here & follow IMM here:
Oilex rises 15% to 0.64p a share
Oilex (OEX) continues to rise following its restoration to AIM and favourable high court decision to transfer GSPC's participating interest (PI) in the Cambay PSC.
The legal dispute arose from GSPC's ongoing failure to pay its PI share of Cambay PSC expenses.
Managing Director, Joe Salomon, said: “Importantly, the Judge has recognised that Cambay is in the national interest, and Oilex is committed to meeting its undertakings to the GoI and contributing to India's energy security".
Read more here & follow PCGE here:
See all today's AIM Risers here
